The Size of the Micro Guide Catheters Market in the Asia Pacific is valued at USD XX Billion in 2019 and is projected to reach USD XX billion by 2024, increasing at a CAGR of XX% during the forecast period 2019-2024.
A catheter is a thin tube inserted into the body when performing surgery. It is called catheterization. It is produced from medical grade substances. They can be used in the treatment of various diseases like urological, neurovascular, cardiovascular, ophthalmic to gastrointestinal.
A micro guide catheter is built for approaching highly intricate lesions in the anatomy via the most intricate vessels, cavities or ducts. The stainless steel braid reinforces the tensile strength and improves the reliability of the catheter. This is an advantage over other conventional catheters. Its lumen is tapered provides enhanced guidewire control in the body.
The risk with catheter material and functioning can inhibit market growth. Sometimes the polymer becomes weak is often know to have fractured which then requires additional surgery thereby losing patient compliance and raising the cost of surgery. The constant healthcare sector improvements and a large amount of population base in the Asia Pacific region are anticipated to drive the demand in the Asia Pacific market.
Asia Pacific Micro Guide Catheters Market has been segmented and sub-segmented into the following categories
On the basis of the therapeutic area, the cardiovascular catheter is the leading category in the market.
Top Companies leading the Asia Pacific Micro Guide Catheters Market Profiled in the Report are Lake Region manufacturing Inc., Boston Scientific Corporation, Volcano Corporation, Micro Therapeutics Inc., LuMend Corporation, Terumo Europe N.V., Covidien AG, ASAHI INTECC Company Limited, Merit Medical Systems Inc.,
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Over-the-wire micro guide catheter
5.1.3 Flow directed micro guide catheter
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Therapeutic Area
5.2.1 Introduction
5.2.2 Neurovascular
5.2.3 Cardiovascular
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 End User
5.3.1 Hospitals
5.3.2 Specialty Clinics
5.3.3 Ambulatory Surgery Centers
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Therapeutic Area
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Therapeutic Area
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Therapeutic Area
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
6.7 Rest of APAC
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 LuMend Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Terumo Europe N.V.
8.3 Covidien AG
8.4 ASAHI INTECC Company Limited
8.5 Lake Region manufacturing Inc.
8.6 Boston Scientific Corporation
8.7 Volcano Corporation
8.8 Micro Therapeutics Inc
8.9 Merit Medical Systems Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
